b 669 has been researched along with n-formylmethionine leucyl-phenylalanine in 1 studies
| Studies (b 669) | Trials (b 669) | Recent Studies (post-2010) (b 669) | Studies (n-formylmethionine leucyl-phenylalanine) | Trials (n-formylmethionine leucyl-phenylalanine) | Recent Studies (post-2010) (n-formylmethionine leucyl-phenylalanine) |
|---|---|---|---|---|---|
| 16 | 0 | 0 | 6,716 | 53 | 356 |
| Protein | Taxonomy | b 669 (IC50) | n-formylmethionine leucyl-phenylalanine (IC50) |
|---|---|---|---|
| fMet-Leu-Phe receptor | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, R; Krajewska, MM | 1 |
1 other study(ies) available for b 669 and n-formylmethionine leucyl-phenylalanine
| Article | Year |
|---|---|
An in vitro comparison of the effects of the prooxidative riminophenazines clofazimine and B669 on neutrophil phospholipase A2 activity and superoxide generation.
Topics: Adult; Anti-Infective Agents; Arachidonic Acids; Clofazimine; Humans; In Vitro Techniques; Lipopolysaccharides; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phospholipases A; Phospholipases A2; Superoxides | 1993 |